Glossary of Terms
Acetylcholine (noun): a chemical messenger (transmitter) released by cholinergic nerves in the striatum area of the brain. It is involved in many brain functions, such as memory and control of motor activity. There appears to be an interplay between the actions of acetylcholine and dopamine.
Action tremor (noun): a tremor that occurs or increases when the hand is moving voluntarily
Adjunctive (adjective): supplemental or secondary (but not essential) to the primary agent. Sometimes used to describe medications used to enhance levodopa therapy
Agonist (noun): a chemical or drug that enhances the activity of a neurotransmitter such as dopamine
Akinesia (noun): delay in initiating movement; inability to move; "freezing"
Ancillary (adjective): auxiliary; serving as an aid
Antioxidant (noun): an agent that prevents the loss of oxygen in chemical reactions
Anxiolytic (noun): an agent or a class of medications that reduce anxiety
Apoptosis (noun): a form of cell death in which cells shrink and disappear. Sometimes referred to as "cell suicide". In Parkinson disease, some scientists believe that the nerve cells in the substantia nigra portion of the brain die by apoptosis.
Ataxia (noun): loss of balance
Athetosis (noun): slow, involuntary movements of the hands and feet
Autonomic nervous system (noun): the system that controls involuntary body functions
Blepharospasm (noun): involuntary clinching of the eyelid
Blood-brain barrier (noun): the protective membrane that separates the bloodstream from brain tissue
Bradykinesia (noun): slowness of movement
Bradyphrenia (noun): slowness in thought processing
Chorea (noun): excessive involuntary movements, ranging from twisting or writhing to flailing movements of the extremities
Cogwheeling (noun): a ratchet-like movement in the joints, characteristic of Parkinson disease
Delusion (noun): false, fixed, idiosyncratic belief, not substantiated by sensory or objective evidence
Dementia (noun): a broad complex of symptoms such as disorientation, confusion, memory loss, impaired judgment, and alterations in mood and personality -- which symptoms can arise from a variety of causes
DNA (deoxyribonucleic acid) (noun): the basic chemical substance that makes up the gene
Dysarthria (noun): low voice volume or muffled speech
Dyskinesia (noun): abnormal, involuntary body movements that can appear as jerking, fidgeting, twisting, and turning movements; frequently induced by medications taken by Parkinson patients. Dystonia, athetosis, and chorea are forms of dyskinesias
Dysphagia (noun): difficulty in swallowing
Dystonia (noun): involuntary spasms of muscle contraction which cause abnormal movements and postures
Endogenous (adjective): originating internally; developing from within, rather than caused by external factors; the opposite of exogenous
Essential tremor (ET) (noun): a condition more common than Parkinson disease, which often includes shaking of the hands or head, and an unsteady quality of the voice
Etiology (noun): the causes or origins of a disease. The etiology of Parkinson disease is not known.
Exogenous (adjective): originating externally; arising from external rather than internal factors; the opposite of endogenous
Festination (noun): short, shuffling steps
Free radicals (noun): toxic substances that are continuously produced by all cells of the human body
Freezing (noun): temporary, involuntary inability to take a step or initiate movement
Glutamate (noun): a salt or ester of glutamic acid, related to the hydrolysis of proteins
Half life (noun): the time taken for the concentration of a drug in the bloodstream to decrease by one half. Drugs with a shorter half life must be taken more frequently.
Hallucinosis (noun): a state of experiencing hallucinations
Hydrophilic (adjective): capable of uniting with or taking up water
Hypomimia(noun): decreased facial expression due to rigidity of facial muscles
Idiopathic (adjective): of unknown origin
Lewy bodies (noun): pink-staining spheres found in nerve cells, considered to be a pathological marker for Parkinson disease
Livido reticularis (noun): purplish or bluish mottling of the skin caused by certain medications taken by Parkinson patients
Micrographia (noun): small, cramped handwriting
Myoclonus (noun): abrupt, jerking movements of the arms or legs, usually occurring during sleep
Neuroleptics (noun): drugs that block dopamine receptors, usually prescribed to treat psychiatric symptoms
Neuron (noun): a cell that generates or conducts electrical impulses to carry information from one part of the brain to another
Neurotransmitter (noun): a biochemical substance (such as dopamine, acetylcholine, or norepinephrine) that carries impulses from one nerve cell to another
Neurotrophic factors (noun): substances that prevent nerve cells from committing apoptosis
Norepinephrine (noun): chemical transmitter involved in regulating the involuntary nervous system
Off-On phenomena (noun): sudden, unpredictable changes in motor performance by patients on levodopa therapy
Orthostatic hypotension (noun): a drop in blood pressure upon standing; can cause fainting
Palsy (noun): paralysis of a muscle group
Pathogenesis (noun): the production or development of a disease
PET (positron emission tomography) (noun): an imaging method that allows one to visualize brain dopamine systems following the injection of a radioactive analog of levodopa (fluorodopa)
Pharmacodynamics (noun): the study of the relationship of drug concentration to drug effect -- what the drug does to the body
Pharmacokinetics (noun): the study of the absorption, distribution, metabolism, and excretion of drugs -- what the body does to the drug
Postural tremor (noun): the rhythmic shaking of the hands with arms outstretched
Resting tremor: characteristic tremor that occurs as one of the primary symptoms of Parkinson's Disease, typically present in arm, leg, lips, chin or tongue. Occurs or exacerbates when at rest; decreases with active motions.
Rigidity (noun): increased resistance noted to the passive movement of a limb
Sialorrhea (noun): drooling; increased salivation
Striatum (noun): the area of the brain that controls movement, balance, and walking
Substantia nigra (noun): area of the brain where cells produce dopamine
Wearing-off phenomena (noun): waning of the effects of a dose of levodopa prior to the scheduled time for the next dose, resulting in decreased motor performance